All News

NASDA has reignited their support to raise the THC limit for hemp to 1.0%.

Bills placed before the South Dakota Senate Health and Human Services Committee proposed changes to the state’s medical cannabis program.

In a shocking move, the New York State Cannabis Control Board cancelled a monthly meeting that was set to discuss rules on home growing and new license applications.

A new study examined the impact of cannabis use on driving performance in older adults who were regular cannabis users.

A recently published national survey collected data on cannabis use for pets.

Sipp Industries, Inc., reaches a distribution agreement with SinuSave® regarding their SinuSave® CBD Nasal Spray products.

An East Coast cannabis farm receives recognition from the third-party nonprofit for its regenerative growing methods.

NJBAC’s Cannabis Training Academy welcomed their first set of instructors to the program.

Germany is on the path to legalize recreational cannabis this year, but challenges are surfacing.

A new bill to define cannabis flower as an accepted form of medical cannabis recently advanced through a subcommittee.

Minnesota regulators believe that the state will be needing a minimum of 381 cannabis dispensaries.

A cannabis-based treatment was shown to be effective for cognitive disfunctions.

Europe is planning to host a multi-stakeholder workshop in April 2024 on medical psychedelics, where they plan to establish regulatory guidelines.

A new study looked into the possibilities of cannabis being used as a treatment in preventing and treating COVID-19, as well as Long-COVID.

A recently published observational study examined the risks of medical cannabis for developing various heart conditions.

Vetoed last year, the bill would allow dispensaries to sell non-cannabis products along with cannabis.

The HHS finds conclusive evidence for medical cannabis use and agreed with the FDA’s recommendation to reschedule cannabis as a Schedule III drug.

A plan for a medical cannabis program in Wisconsin was revealed earlier this week.

Cannabis legalization in Thailand takes a hit from new legislation which plans to ban recreational cannabis use.

The Attorney General recently drafted a bill to legalize recreational cannabis in the state and also provided the office’s position on the issue.

Ispire Technology Inc. recently obtained ISO certifications for their manufacturing facility located in Malaysia.

Healer’s first webinar of the year provided a research update on studies examining cannabis used as a treatment for different neurologic conditions.

The study tested how commercially-available cannabis products affect the experiences of exercising.

On January 10, 2024, the Connecticut for Accessible Psychedelic Medicine (CAPM) held an online and in person forum with lawmakers and experts in Hartford, Connecticut.

A recent study explored cannabinoids as an alternative treatment for neuropathic pain from spinal cord injuries.

Ziel secured their first GMP certification with their Radio Frequency technology for cannabis microbial control in the EU marketplace.

A new study involving veterans reported beneficial effects of ibogaine as a therapeutic treatment.

The UFC has officially removed cannabis from their banned substances list.